Rosa D. Grembiale

Catanzaro, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Real-world damage accrual in Sjögren's disease: a 5-year multicentre GIRRCS cohort analysis.

Real-world damage accrual in Sjögren's disease: a 5-year multicentre GIRRCS cohort analysis.

Journal: RMD open

Published: January 25, 2026

The Impact of Sex on the Pattern and Clinical Response of Early Psoriatic Arthritis: Real-life Data from the Italian Prospective SIRENA Study.

The Impact of Sex on the Pattern and Clinical Response of Early Psoriatic Arthritis: Real-life Data from the Italian Prospective SIRENA Study.

Journal: Rheumatology and therapy

Published: May 28, 2025

Novel Biomarker for Antimitochondrial Antibodies in Systemic Sclerosis Patients.

Novel Biomarker for Antimitochondrial Antibodies in Systemic Sclerosis Patients.

Journal: Journal of immunology research

Published: May 12, 2025

Primary versus systemic sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors.

Primary versus systemic sclerosis-associated Raynaud's phenomenon: relationship with clinical and environmental factors.

Journal: Clinical and experimental rheumatology

Published: July 25, 2024

Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus.

Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus.

Journal: Autoimmunity reviews

Published: May 12, 2024

Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study.

Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study.

Journal: International journal of rheumatic diseases

Published: November 08, 2023

Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis.

Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis.

Journal: Clinical immunology (Orlando, Fla.)

Published: June 28, 2023

Persistent Pancytopenia as a Long-COVID Manifestation in a Patient with Adult-Onset Still's Disease: A Case Report.

Persistent Pancytopenia as a Long-COVID Manifestation in a Patient with Adult-Onset Still's Disease: A Case Report.

Journal: Medicina (Kaunas, Lithuania)

Published: May 31, 2023

Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study.

Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study.

Journal: Journal of clinical medicine

Published: March 15, 2023

Decreased Pulse Wave Velocity in a Systemic Sclerosis Population: Preliminary Results from a Cross-Sectional Study.

Decreased Pulse Wave Velocity in a Systemic Sclerosis Population: Preliminary Results from a Cross-Sectional Study.

Journal: Journal of personalized medicine

Published: October 28, 2022

Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region.

Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region.

Journal: Pharmaceutics

Published: September 30, 2022

Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.

Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.

Journal: Journal of clinical medicine

Published: June 24, 2022

Showing 1-12 of 63

Last Updated: 09/26/2026